🟢 Cue Biopharma is trading 11.33% up today with no confirmed catalyst

Cue Biopharma is trading 11.33% up at $34.60, with the cause unclear.

• Gains extended from August 11 through August 13; no verified company-specific announcement dated August 14, 2026 was identified.
• Broader markets are lower, so macro sentiment does not explain the advance.
• Latest notable filing: August 12 Form S-3 for a potential 1,505,570-share selling-stockholder offering; latest official release: August 3 CFO appointment and CUE-221 IND update. Neither is explicitly linked to today’s rise; reliable volume data is unavailable.